家族をがんから守るための、新しいアプローチの創造

For Veterinarians and Pet Owners

For Health Care Professionals

At MT3, research and development with a focus on a new radiotherapy that utilizes the "radiosensitizer” is in progress. At present, it is at a clinical trial stage of drugs for veterinary use. Development is being conducted with the future goal of achieving a status of medicinal product for human use.

R&D Library

The following are R&D reports with regard to the radiosensitizer, LAVURCHIN.